PE20200399A1 - Metodo para preparar intermedio de derivado de 4-metoxipirrol - Google Patents

Metodo para preparar intermedio de derivado de 4-metoxipirrol

Info

Publication number
PE20200399A1
PE20200399A1 PE2019002401A PE2019002401A PE20200399A1 PE 20200399 A1 PE20200399 A1 PE 20200399A1 PE 2019002401 A PE2019002401 A PE 2019002401A PE 2019002401 A PE2019002401 A PE 2019002401A PE 20200399 A1 PE20200399 A1 PE 20200399A1
Authority
PE
Peru
Prior art keywords
compound
chemical formula
prepare
molar ratio
whose molar
Prior art date
Application number
PE2019002401A
Other languages
English (en)
Inventor
Jeong-Taek Shin
Jeong Hyun Son
Deok Ki Eom
Chun Ho Lee
Original Assignee
Dae Woong Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma
Publication of PE20200399A1 publication Critical patent/PE20200399A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se refiere a un metodo para preparar un compuesto de Formula Quimica 1, que comprende las siguientes etapas: 1) hacer reaccionar el compuesto de Formula Quimica 1-1 con un compuesto de Formula Quimica 1-2 cuya razon molar es de 10:1 a 1:10, para preparar el compuesto de Formula Quimica 1-3; 2) hacer reaccionar el compuesto de Formula Quimica 1-3 con anhidrido acetico cuya razon molar es de 1:1 a 1:32 , en presencia de una base que puede ser carbonato de potasio, carbonato de sodio, entre otros, para preparar el compuesto de Formula Quimica 1-4; 3) hacer reaccionar un compuesto de Formula Quimica 1-4 en presencia de una base cuya razon molar es de 1:1 a 1:10 , para preparar el compuesto de Formula Quimica 1-5; y 4) hacer reaccionar un compuesto de Formula Quimica 1-5 con sulfato de dimetilo cuya razon molar es de 1:1 a 1:10 en presencia de una base para preparar el compuesto de Formula Quimica 1. Dicho metodo se emplea para preparar productos intermedios de derivados de 4-metoxipirrol, no requiere una elevada temperatura de reaccion, se usan reactivos mas economicos y no explosivos mejorando asi el rendimiento en su totalidad.
PE2019002401A 2017-05-31 2018-05-31 Metodo para preparar intermedio de derivado de 4-metoxipirrol PE20200399A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170067646A KR102233456B1 (ko) 2017-05-31 2017-05-31 4-메톡시피롤 유도체의 중간체 제조 방법
PCT/KR2018/006188 WO2018221971A1 (en) 2017-05-31 2018-05-31 Method for preparing intermediate of 4-methoxypyrrole derivative

Publications (1)

Publication Number Publication Date
PE20200399A1 true PE20200399A1 (es) 2020-02-26

Family

ID=64456008

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2019002401A PE20200399A1 (es) 2017-05-31 2018-05-31 Metodo para preparar intermedio de derivado de 4-metoxipirrol

Country Status (23)

Country Link
US (1) US10710961B2 (es)
EP (2) EP4219448A1 (es)
JP (1) JP6799177B2 (es)
KR (1) KR102233456B1 (es)
CN (1) CN110637009B (es)
AU (1) AU2018278731B2 (es)
BR (1) BR112019024976A2 (es)
CA (1) CA3061708C (es)
CL (1) CL2019003449A1 (es)
CO (1) CO2019012686A2 (es)
DO (1) DOP2019000292A (es)
EC (1) ECSP19081839A (es)
JO (1) JOP20190264A1 (es)
MA (1) MA50517A (es)
MX (1) MX2019014323A (es)
MY (1) MY193162A (es)
NZ (1) NZ758743A (es)
PE (1) PE20200399A1 (es)
PH (1) PH12019502638A1 (es)
RU (1) RU2718920C1 (es)
SA (1) SA519410408B1 (es)
TN (1) TN2019000300A1 (es)
WO (1) WO2018221971A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
WO2022051979A1 (zh) * 2020-09-10 2022-03-17 广东莱佛士制药技术有限公司 一种制备钾离子竞争性阻滞剂中间体的方法
CN112094219B (zh) * 2020-09-10 2022-08-05 广东莱佛士制药技术有限公司 一种制备钾离子竞争性阻滞剂中间体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
KR100286874B1 (ko) * 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
JP4898683B2 (ja) 2004-09-03 2012-03-21 ユーハン・コーポレイション ピロロ[2,3−c]ピリジン誘導体及びその製造方法
US8048909B2 (en) 2004-09-30 2011-11-01 Takeda Pharmaceutical Company Limited Proton pump inhibitors
DE102004053191A1 (de) 2004-11-04 2006-05-11 Bayer Cropscience Ag 2,6-Diethyl-4-methyl-phenyl substituierte Tetramsäure-Derivate
KR101088247B1 (ko) 2005-12-19 2011-11-30 라퀄리아 파마 인코포레이티드 크로메인 치환된 벤즈이미다졸 및 이들의 산 펌프억제제로서의 용도
US9388133B2 (en) 2012-11-19 2016-07-12 Jiangsu Hansoh Pharmaceutical Co., Ltd. Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof
KR101613245B1 (ko) 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형

Also Published As

Publication number Publication date
CO2019012686A2 (es) 2020-04-01
MX2019014323A (es) 2020-02-10
WO2018221971A1 (en) 2018-12-06
BR112019024976A2 (pt) 2020-06-23
MA50517A (fr) 2020-09-09
DOP2019000292A (es) 2019-12-15
JOP20190264A1 (ar) 2019-11-12
PH12019502638A1 (en) 2020-07-13
KR102233456B1 (ko) 2021-03-29
TN2019000300A1 (en) 2021-05-07
EP3630722A1 (en) 2020-04-08
EP4219448A1 (en) 2023-08-02
CA3061708C (en) 2021-06-22
JP2020518647A (ja) 2020-06-25
AU2018278731A1 (en) 2019-11-21
KR20180131081A (ko) 2018-12-10
US10710961B2 (en) 2020-07-14
AU2018278731B2 (en) 2021-02-18
SA519410408B1 (ar) 2021-10-21
NZ758743A (en) 2022-07-29
ECSP19081839A (es) 2019-11-30
CN110637009B (zh) 2023-11-10
US20200181079A1 (en) 2020-06-11
JP6799177B2 (ja) 2020-12-09
RU2718920C1 (ru) 2020-04-15
EP3630722A4 (en) 2020-10-21
MY193162A (en) 2022-09-26
CA3061708A1 (en) 2018-12-06
CL2019003449A1 (es) 2020-03-27
CN110637009A (zh) 2019-12-31

Similar Documents

Publication Publication Date Title
PE20200399A1 (es) Metodo para preparar intermedio de derivado de 4-metoxipirrol
AR114631A1 (es) Métodos e intermedios para preparar compuestos de piridina
PE20190180A1 (es) Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas
AR094948A1 (es) Preparación de haloalcoxiarilhidracinas y los intermediarios a partir de los mismos
AR087321A1 (es) Metodo para preparar surfactantes a base de acido acilamidocarboxilico graso
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
PE20090758A1 (es) Un proceso para la preparacion de compuestos de aminodiol protegidos con oxazolina, utiles como intermediarios para florfenicol
AR048875A1 (es) Un proceso para preparar montelukast y compuestos intermedios para el mismo
PE20210151A1 (es) Metodo para preparar intermedio de derivado de 4-metoxipirrol
AR051341A1 (es) Proceso para la preparacion de derivados de [1,4,5]-oxadiazepina
AR127380A2 (es) Método para elaborar una solución acuosa de leucoíndigo libre de anilina o libre de anilina y n-metilanilina, solución estable acuosa de leucoindigo, método para su elaboración, aparato y uso
CL2008003059A1 (es) Metodo para preparar tigeciclina por formacion de un compuesto intermediario nitrado en presencia de una gas inerte y con aislacion de dicho intermediario
EA201990237A1 (ru) Новые способы получения стимуляторов растворимой гуанилатциклазы
AR094253A1 (es) Composiciones acuosas de cloquintocet-mexilo de temperatura estable
AR060622A1 (es) Proceso para la preparcion del ester 2-[ 4-(4- fluoro-2 - metil-1h -indol-5- iloxi)-5-metil pirrolo [2,1-f] [ 1,2,4] triazin -6-iloxi] -1- metiletilico del acido [(1r),2s ] -2- aminopropinoico
ES2663469T3 (es) Proceso para la preparación de abiraterona y acetato de abiraterona
MX2018009831A (es) Proceso para preparar compuestos de aminotiolester y sus sales.
MX2018016270A (es) Produccion de anhidrido de sulfonilazida.
GB959799A (en) Angular carboxylic lactam n-sulphonates and their preparation
BR112023000029A2 (pt) Método de preparação do composto de fenilisoxazolina
WO2012142169A3 (en) Mild anionic surfactants suitable for personal care compositions
Gadekar et al. Reductive removal of methoxyacetyl protective group using sodium borohydride
IES20180088A2 (en) Drugs intermediates 2-ethylhexanoic acid synthesis method
TH1901006931A (th) วิธีการจัดเตรียมสารขั้นกลางของอนุพันธ์ 4-เมธอกซีพิร์โรล
PL410423A1 (pl) 4-chloro-2-metylofenoksyoctany alkoksymetylobis(2-hydroksyetylo)metyloamoniowe,  sposób otrzymywania i zastosowanie jako środków  ochrony roślin